<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 233 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page232.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=233">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 233 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 233</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=233"><img src="../thumb/233.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Dermatologicals / Ophthalmics - 14.9 / 15 / 15.1                               2020-04 / 197
       IRUXOL MONO, Smith & Nephew [P/S] &  Childr.&gt;2 yrs.: 0,03 %: 2xdly.for up to 3 wks.then reduc.to 1xdly
       Collagenase clostridiopeptidase A 1,20 u, proteases 0,24 u/g.  until clear.of les.  15  OPHTHALMICS
       Indications: Wound cleans.in various types of ulcerat. incl.decubit.  Adults & childr.&gt; 16 yrs.: 0,03 % & 0,1 %: Start with 0,03 % 2xdly.
       ulc.& poor.heal.necrot.wounds  contin.until clear.of les., if sympts. not resolv.start treatm.with 0,1 %
       (S1) OINT. G1633.             2xdly. Attempt to reduc.freq./use of low.strength if poss.  15.1  Anti-infectives
       734012-012: 10 g, R122,37     Contraindications: Immunocompromis.adults & childr., mac-
       734012-004: 30 g, R367,20                                  VIGAMOX (MDR Listing)
       Dosage: Apply 1xdly.          rolide hypersens.
       Contraindications: Other topic.preps.  Side effects: Skin irrit./-burn./-prurit./-erythema/ -warm.sensat./-  BROLENE, (Adcock Ingram) Genop [P/S]
       Side effects: Burn.sensat., loc.irrit.  pain/-rash & -paraesthes., herpes vir.infects., Kaposi’s variceliform   Propamidine isethionate.
       See also MDR page 690.        erupt., folliculit., acne, paraesthes.& dyaesthes., alcoh.intol.  Indications: Eye & eyelid infects., eye infect. prophylax.aft.mi-
                                                                  nor eye injur.
       METVIX, Galderma [P/S]        Warning and special precautions: Malign.incl. cutan.& other   (S0) EYE DROPS, [P/S] H1212. 1 mg/ml.
                                     types of lymphoma & skin cancers have been report.with the use
       Methyl aminolevulinate.                                    710466-005: 10 ml, R55,86
       Indications: Thin or non-hyperkeratotic and non-pigment.ac-  of Protopic, minimise sun/UV expos., safety & effic.not demonst.   Dosage: 1-2 drps. 4x/day for max.1 wk.
       tinic keratos.on face and scalp when other ther.consid.less ap-  for &gt;12 mnths., not recomm.in genet. epiderm. barrier defects due   Special precautions: Discont.in cases of sensitis., adverse effs.on
       propriat., superfic.&/ nodul. basal cell Ca unsuit.for other avail.  to incr.syst.absorpt. potent, extens.skin involvem.over extend per.of   corn.permeability & disrupt.of corn.epithelium poss.reg.ophthalm. ex-
       ther.due to poss.treatm.relat.morbid.& poor cosmet. outcome,   time esp.childr., do not apply to potent./pre-malign. areas, investig.&   aminat.with prolong.use, extens.ocul.surf.dis.
       squamous cell carcinoma in situ (Bowen’s dis.) when surg.excis.  observ.any lymphadenopathy prior to init.ther., concom. system. ad-
       consid.less appropriate.      min.known CYP3A4 inhibit.in widespr. &/erythroderm.dis., admin.  CHLORAMEX OPHTHALMIC OINTMENT, (Aspen Pharma-
       (S4) CREAM, A38/26/0528. 160 mg/g.  vaccinat.prior to commencem./ dur.treatm free interv.with 14 days or   care: Pharma) Pharmacare [P/S]
       705611-001: 2 g, R3 753,35    28 days for live attentuat.vaccinat.betw.last applic., consid.alternat.  Chloramphenicol.
       Dosage: Two sess.1 wk.apart. Prepare affect.area to remove scales   vaccinat., reproduct.toxicity follow.system.admin., pregn.& lactat.,   Indications: Superfic.eye & eyelid infects.
       and crusts and roughen les.surf. Apply 1 mm thick layer with spatula   childr.und.2 yrs., do not apply emollients to same area within 2 hrs.,   (S4) OINT. H1193. 10 mg/g.
       to les.& surround. 5-10 mm norm.skin. Cover with occlus. dress.&   other concom.topic.meds/system.ster./ immunosuppress. agents & in   713724-005: 3,5 g, R13,58
       leave x3 hrs. Remove dress., clean area with saline & immed.ex-  Dosage: Apply small amnt.4xdly.
       pos.les.to red light with contin. spect.of 570-670 nm and tot.light   clinic.infect.atop. dermatit.not assess., treat clinic.infects.bef. admin.,   Contraindications: Prev./fam.bld.dyscras.hist. incl. aplast.anaem.
              2
       dos.of 75 J/cm  at les.surf. Red light with narr.spectrum giv.same   do not admin.in presc.of herpes & viral infects., loc.immunosuppress.  Side effects: Less.freq: Bone marr.depress., aplast. anaem., bld.
       activat.of accumulat.porphyr.may be used. Light intens.at les.surf.   potent unknown for treatm. beyond 1 yr., hepat.fail.  dyscras., anaphylax., angioed., trans.burn.& sting., urticar., vesic.&
       should not exceed 200 mW/ cm . Use only CE mark.lamps equipp.   maculopap. dermatit., fev.
                     2
       with necess.filters &/reflect.mirrors. Admin.correct light dos. Light   RETACNYL, Galderma [P/S]  Warnings and special precautions: Ophthal. use only, supplem.topic.
       dos.determin.by var.fact.& lamp should be used accord.to manual.   Tretinoin.  ther.with appropr. syst. treatm. in case of sev.infects., sensitisat.& emerg.
       Monit.light dos. deliv.if poss. Multiple les.may be treat.dur.same   Indications: As adjunct.treatm.of photodamag. skin due to sun ex-  of resist.organ.with prolong.use, medic.advice if no improvem. aft.2 days/
       session. Assess respons.aft.3 mnths. Confirm BCC & Bowen’s dis   pos.in pts.unrespons.to skin care programs & sun avoid.  if sympts.worsen/eye injury/ other concom.eye drops or oint./rec.conjunc-
       les.respons.by histologic.biopsy. Les.that show non-complete re-  (S3) CREAM, 29/13.5/0353. 0,5 mg/g.  tivit./ glauc./ dry eye syndr./eye surg/laser treatm.in last 6 mnths., do not
       sponse may be re-treat.if desir. Close clinic.monit.of Bowen’s dis.  874752-019: 30 g, R359,08  wear contact lense dur.ther/24 hrs. thereaft., eval.eff.on ability to drive/
       with histology.if necess.recomm.  Dosage: Apply once dly.to affect.areas bef.retir. & aft.wash. Allow   use mach./ tasks req.conc., safety in pregn.& lactat.not est.
       Contra-indications: Morpheaform bas.cell Ca, porphyr., not   area to dry for at least 20-30  mins. bef.applic. Maint: Apply 1-3 x   Interactions: Concom.meds.liable to depress bone marr.funct., poss.
       recomm.dur.pregn., hyperkeratot. actin. keratos., no exper.in   wkly.once max. benef.achiev.  interfers with meds. metabol. by hepat.microsom.enzymes, effs.of cou-
       pts.und.18 yrs., no exper.with pigment./high.infiltrat.les./les   Contra-indications: Safety in pregn.& lactat. not est.  mar. anticoags./warfar/some hypoglycaem eg chlorpropamide & tolbu-
       locat.on genital./Bowen’s les.&gt;40 mm/Bowen’s dis in trans-  Side-effects: Loc.reacts.incl.slight erythem., hypo/ hyperpigmentat.,   tamide.& antiepilept.eg phenytoin enhanc., metabol.incr.by hepat.en-
       plant pts.on immunosuppress.ther.& arsenic expos.hist.there-  highten.UVB suscept., sev.irrit.of eczemat.skin.  zym. induc., poss.decr.effs.of Fe & Vit.B12 in anaem. pts., OC’s act.imp.
       fore not recomm.,             Special precautions: Safety & effic.for use long. than 12 mnths.
       Side-effects: Painf.skin sensat., loc.phototox.of erythema & oed.,   CHLORNICOL EYE OINTMENT, (Ascendis Pharma) Aquila [P/S]
       burn/sting./prick.& tingl.skin, itch., crust., ulcerat., blisters, suppurat.,   not est., effic.in pts.old.than 50 yrs.or on mod.to heavily pigment.skin   Chloramphenicol
       infect., peel., applicat.site reacts., bleed.skin, hypo-/hyper pigmentat.,   not est., discont./reduc.freq.if loc.irrit. warrants, eczema, weather   Indications: Eye infects.
       rash, urticar., eczema, headache, naus., eye pain & irrit., fatig., dizzin.,   extrem., avoid/minim. sunlight expos., pt.educat.advis., avoid eye   (S4) OINT. H1207. 10 mg/g.
       scar, skin sensitisat., allerg.reacts.poss.delay.  cont., eyelids, nose angles, mouth & mucous membr., teratogen.in   713872-004: 3,5 g, R205,81
       Special precautions: Admin.only by photodynam. ther.train.health   experim.animals, concom. topic.meds., peel. agents & abrasiv.esp.  Dosage: Instill into infect.eye 2 or 3xdly
       care prof., exper.of long term effic.limit., in absenc.of clinic.exper. dis-  those contain.alcoh.  Contraindications: Min.infects./bact.infects. prophylax., dur.act.im-
       cont. breast feed.x48 hrs.aft.applicat., pt.& operat.to observ.specif.  munisat., concom.other meds. poss.depress.bone marrow., pregn.&
       safety precaut., discont.any UV ther.1 , avoid sun expos.for couple   ROZEX, Galderma [P/S]  lactat., newborns unless life-sav./no alt.treatm.
                       st
       of days, avoid eye contact.   Metronidazole.               Side effects: Poss.ser.& somet.fatal adverse eff., bld. dyscras., bone
                                     Indications: Inflamm.papules, pustul., & erythema of rosacea.  marrow depress., sev.irrevers. aplast.anaem., haemolyt.anaem.poss.
       OILATUM PLUS, GSK [P/S]       (S3) GEL. 29/13.4.2/0771. 7,5 mg/g.  in gluc.-6-phosph. defic.dehydrogen.activ., periph./opt. neurit., opt.at-
       Benzalkonium Cl 6 g, triclosan 2 g, light liq.paraffin 52,5 g/100 g.  820210-005: 30 g, R239,69  rophy & blindn., sens./Jarisch-Herxheim.-like reacts.
       Indications: Temp.relief of eczam.sympts.& reduc. risk of infect.  Dosage: Adults: Apply & rub a thin film 2xdly to affect.area.  Special precautions: Grey syndr.risk, avoid repeat. course &
       LIQ, 31/13.9/0181.                                         prolong.ther., chloramphen. absorpt., discont.ther.in case of tox.
       838675-018: 150 ml, R82,57    Contra-indications: Pregn.& lactat., childr.not recomm.  sympt., bone marrow aplas./hypoplas.poss.wks./mnths.aft. ther.,
       Dosage: Add 1-2 capf.to bath of 10-20 cm deep and soak for 10-  Side-effects: Watery eyes, loc.irrit., trans.redn., mild dryn.&burn.  routine bld.exam.advis., ren.fail., imp.liv. funct., neonat.with im-
       15 min.once dly.              Special precautions: Bld.dyscras./hist.thereof, reduc.freq./discont.  mat.metab.process.
       Infts: Add 1 ml to baby bath/basin of water.  if loc.irrit.occurs, avoid.UV expos.,   Drug interactions: Poss.interact.with meds. metabol.by hepat.
       Contraindications: Infts.less than 6 mnths.old, concom.soap use,   Drug interactions: Oral metronidazole potent. anticoag.eff of   microsom.enzym., effs.of some coumar.anticoags./hypoglycaem.
       direct.applic.to skin.        coumar.& warfar.             agents/anti-epilept. enhanc., half-life/plasma conc.poss.aff.by par-
       Side effects: Mild prurit.                                 acetamol/phenobarb./phenytoin/rifampicin.
       Special precautions: Avoid eyes, slip.in bath, discont. in case   THROMBOPHOB, Winthrop [P/S]
       of sev.irritat.               Heparin.                     CILOXAN, Novartis [P/S]
                                     Indications: Circulat.disords., superfic.phlebit.& thrombophlebit.,
       PHENERGAN, Zentiva [P/S]      varicos.veins., indol.ulc., bed sores, ext.haemorrh., accidents & injur.,   Ciprofloxacin.
                                                                  Indications: Corn.ulc.& conjunctiv.caus.by suscept.bact.
       Promethazine 2 g, dibromopropamidine isethionate 0,15 g/100 g  sprains, strains, contus., haematomas., scar tiss.to prev.keyloid tiss.  (S4) SOL. Z/15.1/202. 3 mg/ml.
       Indications: 1  & 2  degr.burns, scalds, insect bites and stings.  (S1) GEL, [P/S] G1635. 20 000 iu/100 g.
                nd
              st
       (S2) CREAM, G1334             770671-004: 25 g, R75,59     794104-002: 5 ml, R1282,84  st
                                                                  Dosage: Corneal ulc/abscesses: 1  day 2 drps.in affect. eye
       754722-007: 25 G, R54,62
       Dosage: Burns & scalds: Apply directly to affect.area. Cover with   Dosage: Apply thin.to skin 2-3xdly.  every 15 mins. x6 hrs, then 2 drps.every 30 mins.for remain.of day.
                                                                  2  day: 2 drps.hrly. 3  -14  day: 2 drps 4 hrly. Dos.regim.may be ex-
                                                                             th
                                                                           rd
                                                                   nd
       dress.when indicat.           Special precautions: Avoid eye contact, apply to open wound
       Insect bites: Apply immed.& rep.2-3xdly or more oft.if necess.  edges only.  tend.at discret.of physic.
                                                                  Bact.conjunctivit: First 2 days 1-2 drps.in conjunctiv. sac. 2 hrly
       Contraindications: Prolong.treatm.of burns & scalds, ac.vesicul.&   WART MAGIC LIQUID, (Ascendis Pharma) Beige Pharma [P/S]
       exudat.dermatos.              Podophyllin 0,75 g, salicylic acid 0,5 g, benzoin tinct.co.to 5 ml/5 ml  while awake, then 1-2 drps. 4 hrly while awake until infect.resolv.
                                                                  Dos.regim. may be extend.at discret.of physic.
       Side effects: Photosensitisat., skin sensitisat.
       Special precautions: Discont.in case of photosenitisat.or if no   Indications: Topic.treatm.of warts/vener.warts, corns & callous.  (S4) OINT. 35/15.1/0410. 3 mg/g
       improvem.within 3 days, brok./eczema.skin, restrict applicat.if   (S2) SOL, G1995  701064-001: 3,5 g, R192,68
       large areas affect.to avoid system.absorpt.effs.eg.drowsin., stains   813990-009: 7 ml, R57,36  Dosage: Corneal ulc/abscesses: Apply 1,25 cm into conjunctiv.
       cloth./bedlinen.              Dosage: Apply to wart/corn at night. Allow to dry. Wash.with soap   sac every 1-2 hours around the clock for 2 days then 4 hrly for furth.12
                                                                  days. Dos.regim.may be extend.at discret.of physic.
       PROTOPIC, (Adcock Ingram) Astellas [P/S]  & water in the morn. Rep.for 4-5 days & wk.later if reqd.  Bact.conjunctivit: Apply 1,25 cm into conjunctiv. sac/lid margin
                                     Special precautions: Apply to affect.area only, discont.applicat.if
       Tacrolimus                    pain/inflamm.exper.dur.treatm., medic.supervis.  3xdly.for 2 days then 2xdly.for furth. 5 days. Dos.regim.may be ex-
       Indications: 0,03 % Second line ther.in adults & childr.over 2 yrs.for   tend.at discret.of physic.
       treatm.mod.to sev.atopic dermatit.  WARTEC, GSK [P/S]      Contraindications: Hypersens.to other quinolon., safety in pregn.&
       0,1 % Mod.to sev.atopic dermatit.in adults not adeq.respons.to   Podophyllotoxin  lactat.not est.
       0,03 % or intol.to convent.ther.  Indications: Penile warts in preputial space, ext. genit.warts in   Side effects: Eye drops: Itch., foreign body sensat., lid marg.crust.,
       (S4) OINT, A40/13.12/0219, A40/13.12/0231  women.          crystals/scales, conjunctiv. hyperaem., corn.sting., keratopathy/ker-
       712758-001: 0,3 mg/g, 30 g, R337,17  (S2) SOL, 28/13.9/0142. 5 mg/ml  atit., allerg.rects., lid oed., tear., photophob., corn.infiltrates, decr.
       712758-002: 0,3 mg/g, 60 g, R674,34                        vis, poss.hypersens.
       712759-001: 1,0 mg/g, 30 g, R373,67  815616-007: 3 ml, R380,78  Eye ointm: Blurr.vis., hyperaem., prurit., decr.vis. acuity, pain, tear.,
       712759-002: 1,0 mg/g, 60 g, R747,33  Dosage: Clean & dry affect.area, paint.warts 2xdly. x3days. If residual   photophob.
       Dosage: Prescr.by medic.profess. Intermitt.not contin.treatm.stop.  warts persist treatm.may be rep.aft. 7 days. Apply sol.to wart only.  Drops & Ointm: Loc.burn., white precipitat, naus., metal.taste, dermatit.
       if no improvem.aft.3 wks.     Contraindications: Open wounds, childr., pregn.& lactat.  Special precautions: Discont.at first sign of rash/ hypersens.re-
       Use on any part of the body, incl.face/neck & flexure areas.except   Side effects: Loc.irrit., tendern., smart., erythema, superfic.epithel.  acts., overgrowth of non-suscept. organ.incl.fung.with prolong.use,
       muc.membr. Do not apply und.occlus. Apply thin layer to affect.areas.  ulcerat., balanoposthit.  init. appropr.meas.in superinfect.examin.pt.with aid of magnificat</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page232.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page228.html">228</a>&nbsp;&nbsp;&nbsp;<a href="page229.html">229</a>&nbsp;&nbsp;&nbsp;<a href="page230.html">230</a>&nbsp;&nbsp;&nbsp;<a href="page231.html">231</a>&nbsp;&nbsp;&nbsp;<a href="page232.html">232</a>&nbsp;&nbsp;&nbsp;<a href="page233.html">233</a>&nbsp;&nbsp;&nbsp;<a href="page234.html">234</a>&nbsp;&nbsp;&nbsp;<a href="page235.html">235</a>&nbsp;&nbsp;&nbsp;<a href="page236.html">236</a>&nbsp;&nbsp;&nbsp;<a href="page237.html">237</a>&nbsp;&nbsp;&nbsp;<a href="page238.html">238</a>
             </td>
             <td width="35%"><a href="page234.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page234.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
